Teplizumab: The First Treatment to Delay the Progression of Type 1 Diabetes.
- Resource Type
- Article
- Source
Clinical Diabetes . Summer2023, Vol. 41 Issue 3, p474-476. 3p.- Subject
- *
THERAPEUTIC use of monoclonal antibodies
*DISEASE progression
*DRUG approval
*TYPE 1 diabetes
*MONOCLONAL antibodies - Language
- ISSN
- 0891-8929